Clinical trial
Assessment Of Statin Treatment Compliance In Dyslipidemia Patients: An Observational Study
NCT00673660 is registered in ClinicalTrials.gov with Pfizer's Upjohn has merged with Mylan to form Viatris Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment Of Statin Treatment Compliance In Dyslipidemia Patients: An Observational Study
- Lead sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2007
- Completion date
- October 31, 2009
- Enrollment
- 375 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
dyslipidemia